Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 22, 2019
Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer
Ana I Matos, Barbara Carreira, Carina Peres, et al.
Advanced Healthcare Materials
|
August 29, 2024
Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer
Cláudio Ferro, Ana I Matos, Luigia Serpico, et al.
Acta Biomaterialia
|
June 26, 2018
α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma
Vanessa Sainz, Liane I F Moura, Carina Peres, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 31, 2025
Polymeric-based neoantigen nanovaccine synergizes with PD-1/PD-L1 modulators, reprogramming the melanoma microenvironment
Bárbara Carreira, Rita C Acúrcio, Ana I Matos, et al.
Nature Nanotechnology
|
August 7, 2019
Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators
João Conniot, Anna Scomparin, Carina Peres, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
February 12, 2025
Off-The-Shelf Multivalent Nanoconjugate Cancer Vaccine Rescues Host Immune Response against Melanoma
Liane If Moura, Alessio Malfanti, Ana I Matos, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
July 11, 2023
Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid Tumors
Ana I Matos, Carina Peres, Barbara Carreira, et al.
Advanced Functional Materials
|
November 5, 2025
Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy
Carina Peres, Ana I Matos, Bárbara Carreira, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 22, 2019
Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer
Ana I Matos, Barbara Carreira, Carina Peres, et al.
Advanced Healthcare Materials
|
August 29, 2024
Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer
Cláudio Ferro, Ana I Matos, Luigia Serpico, et al.
Acta Biomaterialia
|
June 26, 2018
α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma
Vanessa Sainz, Liane I F Moura, Carina Peres, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 31, 2025
Polymeric-based neoantigen nanovaccine synergizes with PD-1/PD-L1 modulators, reprogramming the melanoma microenvironment
Bárbara Carreira, Rita C Acúrcio, Ana I Matos, et al.
Nature Nanotechnology
|
August 7, 2019
Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators
João Conniot, Anna Scomparin, Carina Peres, et al.
Advanced Materials (Deerfield Beach, Fla.)
|
February 12, 2025
Off-The-Shelf Multivalent Nanoconjugate Cancer Vaccine Rescues Host Immune Response against Melanoma
Liane If Moura, Alessio Malfanti, Ana I Matos, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
July 11, 2023
Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid Tumors
Ana I Matos, Carina Peres, Barbara Carreira, et al.
Advanced Functional Materials
|
November 5, 2025
Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy
Carina Peres, Ana I Matos, Bárbara Carreira, et al.
Page
of 2